These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 23025916)
1. Drug-drug interactions between antiretroviral and immunosuppressive agents in HIV-infected patients after solid organ transplantation: a review. van Maarseveen EM; Rogers CC; Trofe-Clark J; van Zuilen AD; Mudrikova T AIDS Patient Care STDS; 2012 Oct; 26(10):568-81. PubMed ID: 23025916 [TBL] [Abstract][Full Text] [Related]
2. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788 [TBL] [Abstract][Full Text] [Related]
3. Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients. Marfo K; Greenstein S Transplant Proc; 2009 Nov; 41(9):3796-9. PubMed ID: 19917390 [TBL] [Abstract][Full Text] [Related]
4. The development of anti-HIV-1 drugs. Lu XF; Chen ZW Yao Xue Xue Bao; 2010 Feb; 45(2):165-76. PubMed ID: 21348415 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review. Miro JM; Ricart MJ; Trullas JC; Cofan F; Cervera C; Brunet M; Tuset M; Manzardo C; Oppenheimer F; Moreno A Transplant Proc; 2010 Nov; 42(9):3887-91. PubMed ID: 21094878 [TBL] [Abstract][Full Text] [Related]
6. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Frassetto LA; Browne M; Cheng A; Wolfe AR; Roland ME; Stock PG; Carlson L; Benet LZ Am J Transplant; 2007 Dec; 7(12):2816-20. PubMed ID: 17949460 [TBL] [Abstract][Full Text] [Related]
10. Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients. Vogel M; Voigt E; Michaelis HC; Sudhop T; Wolff M; Türler A; Sauerbruch T; Rockstroh JK; Spengler U Liver Transpl; 2004 Jul; 10(7):939-44. PubMed ID: 15237382 [TBL] [Abstract][Full Text] [Related]
11. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients. Pea F; Tavio M; Pavan F; Londero A; Bresadola V; Adani GL; Furlanut M; Viale P Antivir Ther; 2008; 13(5):739-42. PubMed ID: 18771060 [TBL] [Abstract][Full Text] [Related]
12. Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study. van Maarseveen EM; Crommelin HA; Mudrikova T; van den Broek MP; van Zuilen AD Transplantation; 2013 Jan; 95(2):397-402. PubMed ID: 23250333 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients. Frassetto L; Baluom M; Jacobsen W; Christians U; Roland ME; Stock PG; Carlson L; Benet LZ Transplantation; 2005 Jul; 80(1):13-7. PubMed ID: 16003227 [TBL] [Abstract][Full Text] [Related]
14. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Jain AB; Venkataramanan R; Eghtesad B; Marcos A; Ragni M; Shapiro R; Rafail AB; Fung JJ Liver Transpl; 2003 Sep; 9(9):954-60. PubMed ID: 12942457 [TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitor dose-finding before kidney transplantation in HIV patients. Pulzer A; Seybold U; Schönermarck U; Stangl M; Habicht A; Bogner JR; Franke J; Fischereder M Transpl Int; 2013 Mar; 26(3):254-8. PubMed ID: 23227980 [TBL] [Abstract][Full Text] [Related]
16. Antiretroviral and immunosuppressive drug-drug interactions: an update. Izzedine H; Launay-Vacher V; Baumelou A; Deray G Kidney Int; 2004 Aug; 66(2):532-41. PubMed ID: 15253704 [TBL] [Abstract][Full Text] [Related]
17. Liver transplantation in HIV/hepatitis co-infection. Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A; J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393 [TBL] [Abstract][Full Text] [Related]
18. Anti-retrovirals and immunosuppressive drug interactions in a HIV-positive patient after liver transplantation. Antonini M; Ettorre GM; Vennarecci G; D'Offizi G; Narciso P; Del Nonno F; Perracchio L; Visco G; Santoro E Hepatogastroenterology; 2004; 51(57):646-8. PubMed ID: 15143883 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial and immunosuppressive drug interactions in solid organ transplant recipients. Berdaguer S; Bautista J; Brunet M; Cisneros JM Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():86-92. PubMed ID: 22542040 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic evaluation of raltegravir and experience from clinical trials in HIV-positive patients. Calcagno A; D'Avolio A; Bonora S Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1167-76. PubMed ID: 26073580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]